RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Myriad Genetics Incorporated

A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.

Top Myriad Genetics Incorporated Articles see all

Displaying items 1-5
  • Genes are complex; gene patents might be more so

     
    Genetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated. An e
  • Diversified media giant weathering defections to ride strong financial standing

    About Discovery Communications Inc. Ticker: DISCA Exchange: Nasdaq What does the company do? Media and entertainment company 2010 Financial report: Total revenues: $3.77 billion Net income: $653 million Q. Please advise me on my shares of Discovery...

    Utah-based Myriad can patent breast cancer genes: court

    Utah-based Myriad can patent breast cancer genes: court
    CHICAGO (Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business. The U.S. Court of Appeals for...

    Genetic cancer test often urged for wrong women

    Genetic cancer test often urged for wrong women
    NEW YORK (Reuters) - Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer women at high risk for the disease, government researchers said. Ovarian cancer isn't very common...

    Ban on patenting DNA cheers researchers

    Ban on patenting DNA cheers researchers
    Researchers hailed the Supreme Court ruling Wednesday that bans the patenting of human DNA, saying it would expand access to genetic testing for disease at lower cost to patients. In a unanimous decision, the justices said Myriad Genetics did not have...